Bayer Research and Development Expenses 2010-2024 | BAYRY

Bayer research and development expenses for the twelve months ending December 31, 2024 were $6.719B, a 15.58% increase year-over-year.

  • Bayer annual research and development expenses for 2024 were $6.719B, a 15.58% increase from 2023.
  • Bayer annual research and development expenses for 2023 were $5.813B, a 16.05% decline from 2022.
  • Bayer annual research and development expenses for 2022 were $6.924B, a 8.14% increase from 2021.

Bayer Research and Development Expenses 2010-2024 | BAYRY

  • Bayer annual research and development expenses for 2024 were $6.719B, a 15.58% increase from 2023.
  • Bayer annual research and development expenses for 2023 were $5.813B, a 16.05% decline from 2022.
  • Bayer annual research and development expenses for 2022 were $6.924B, a 8.14% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Innoviva (INVA)$1.1B